New patent expiration for Merck Sharp drug TEMODAR

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TEMODAR
Annual Drug Patent Expirations for TEMODAR

Temodar is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

TEMODAR drug price trends.

This drug has thirty-three patent family members in twenty-three countries.

The generic ingredient in TEMODAR is temozolomide. One supplier is listed for this compound. Additional details are available on the temozolomide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top